Department of Pediatric Cardiology and Critical Care, Hannover Medical School, Hannover, Germany; European Pediatric Pulmonary Vascular Disease Network, Berlin, Germany.
Department of Pediatric Cardiology and Critical Care, Hannover Medical School, Hannover, Germany; European Pediatric Pulmonary Vascular Disease Network, Berlin, Germany.
J Heart Lung Transplant. 2022 Feb;41(2):187-198. doi: 10.1016/j.healun.2021.10.014. Epub 2021 Oct 29.
We investigated whether RV function recovers in children with pulmonary arterial hypertension (PAH) and RV failure undergoing lung transplantation (LuTx).
Prospective observational study of 15 consecutive children, 1.9 to 17.6 years old, with PAH undergoing bilateral LuTx. We performed advanced echocardiography (Echo) and cardiac magnetic resonance imaging (MRI), followed by conventional and strain analysis, pre- and ∼6 weeks post-LuTx.
After LuTx, RV/LV end-systolic diameter ratio (Echo), RV volumes and systolic RV function (RVEF 63 vs 30 %; p < 0.05) by MRI completely normalized, even in children with severe RV failure (RVEF < 40%). The echocardiographic end-systolic LV eccentricity index nearly normalized post-LuTx (1.0 vs 2.0, p < 0.0001) while RV hypertrophy regressed more slowly and was still evident. We found especially the end-systolic RV/LV ratios by Echo (diameter: 0.6 vs 2.6) or MRI (volumes: 0.8 vs 3.4) excellent diagnostic tools (p < 0.05): Together with RVEF by MRI, these ratios were superior to tricuspid annular plane systolic excursion (TAPSE; p = 0.4551) in assessing global systolic RV dysfunction. Moreover, children with severe PAH had reduced RV 2D longitudinal strain (Echo, MRI; p = 0.0450) and decreased RV 2D radial and circumferential strain (MRI; p = 0.0026 and p = 0.0036 respectively), all of which greatly improved following LuTx.
We demonstrate full recovery of RV systolic function in children within two months after LuTx for severe PAH, independently of the patients' age, weight, and hemodynamic compromise preceding the LuTx. Even in end-stage pediatric PAH with poor RV function and low cardiac output, LuTx should be preferred over heart-lung transplantation.
我们研究了在接受肺移植(LuTx)的肺动脉高压(PAH)和右心室衰竭(RVF)患儿中,RV 功能是否恢复。
对 15 例连续的儿童进行前瞻性观察研究,年龄为 1.9 至 17.6 岁,患有 PAH 并接受双侧 LuTx。我们在 LuTx 前和 LuTx 后约 6 周进行了先进的超声心动图(Echo)和心脏磁共振成像(MRI)检查,然后进行常规和应变分析。
LuTx 后,RV/LV 收缩末期直径比(Echo)、RV 容积和收缩期 RV 功能(RVEF 63%对 30%;p<0.05)通过 MRI 完全正常化,即使在 RV 衰竭严重的儿童中(RVEF<40%)也是如此。LuTx 后超声心动图左室收缩末期偏心指数几乎正常化(1.0 对 2.0,p<0.0001),而 RV 肥厚消退较慢,仍很明显。我们发现,尤其是通过 Echo(直径:0.6 对 2.6)或 MRI(容积:0.8 对 3.4)测量的收缩末期 RV/LV 比值是极好的诊断工具(p<0.05):与 MRI 测量的 RVEF 相结合,这些比值在评估整体收缩期 RV 功能障碍方面优于三尖瓣环平面收缩期位移(TAPSE;p=0.4551)。此外,严重 PAH 患儿的 RV 二维纵向应变(Echo,MRI;p=0.0450)和 RV 二维径向和环向应变(MRI;p=0.0026 和 p=0.0036)降低,这些在 LuTx 后均有显著改善。
我们证明了在严重 PAH 患儿接受 LuTx 后两个月内 RV 收缩功能完全恢复,与患者 LuTx 前的年龄、体重和血液动力学受损无关。即使在终末期儿科 PAH 患儿中,即使 RV 功能不良和心输出量低,LuTx 也应优于心肺移植。